Colin P. Dinney
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)University of Pennsylvania(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Epigenetics and DNA Methylation, Urological Disorders and Treatments, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy(2014)1,717 cited
- Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.(1999)
- → A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci(2010)486 cited
- → Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study(2004)418 cited
- → Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial(2020)417 cited
- → miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy(2009)407 cited